Dudley & Shanley Inc. Has $8.85 Million Stake in Waters Corporation $WAT

Key Points

• Dudley & Shanley Inc. more than doubled its Waters stake in the second quarter, holding 23,590 shares valued at approximately $8.85 million. Institutional investors collectively own 94.01% of Waters’ stock.
• Analysts maintain a generally positive outlook, with Waters receiving a consensus “Moderate Buy” rating and an average price target of $418.10; Barclays raised its target to $460 and rated the stock “overweight.”
• Waters exceeded quarterly expectations, reporting $3.05 in EPS versus the $3.01 consensus and $1.65 billion in revenue versus $1.62 billion expected. Director Christopher A. Kuebler separately sold 3,626 shares for approximately $1.44 million.

Dudley & Shanley Inc. raised its holdings in Waters Corporation (NYSE:WAT - Free Report) by 101.3% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 23,590 shares of the medical instruments supplier's stock after purchasing an additional 11,870 shares during the period. Waters makes up about 1.3% of Dudley & Shanley Inc.'s portfolio, making the stock its 27th largest holding. Dudley & Shanley Inc.'s holdings in Waters were worth $8,847,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Zions Bancorporation National Association UT increased its holdings in shares of Waters by 121.2% during the fourth quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier's stock worth $28,000 after purchasing an additional 40 shares during the period. SHP Wealth Management bought a new stake in shares of Waters in the fourth quarter valued at approximately $32,000. DV Equities LLC bought a new stake in shares of Waters in the fourth quarter valued at approximately $32,000. Anchor Investment Management LLC acquired a new stake in Waters during the first quarter worth approximately $27,000. Finally, Resources Management Corp CT ADV bought a new position in Waters during the 1st quarter worth $27,000. Institutional investors and hedge funds own 94.01% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on WAT shares. Wells Fargo & Company upped their target price on Waters from $370.00 to $400.00 and gave the company an "equal weight" rating in a research report on Wednesday, August 5th. Barclays raised their price target on Waters from $425.00 to $460.00 and gave the stock an "overweight" rating in a research report on Wednesday. Sanford C. Bernstein began coverage on Waters in a research note on Friday, June 26th. They issued an "outperform" rating and a $435.00 price target for the company. Piper Sandler initiated coverage on shares of Waters in a research report on Thursday, June 11th. They set a "neutral" rating and a $400.00 price objective for the company. Finally, Wolfe Research assumed coverage on shares of Waters in a research note on Tuesday, June 2nd. They set an "outperform" rating and a $425.00 price objective on the stock. Three equities research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, Waters presently has an average rating of "Moderate Buy" and a consensus price target of $418.10.

Insider Transactions at Waters

In related news, Director Christopher A. Kuebler sold 3,626 shares of the company's stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the completion of the transaction, the director directly owned 17,808 shares in the company, valued at $7,086,515.52. This represents a 16.92% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.31% of the stock is currently owned by corporate insiders.

Waters Stock Performance

NYSE:WAT opened at $406.94 on Monday. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $414.15. The company has a quick ratio of 0.50, a current ratio of 0.77 and a debt-to-equity ratio of 0.32. The stock's 50-day simple moving average is $373.23 and its 200 day simple moving average is $345.27. The firm has a market capitalization of $39.96 billion, a PE ratio of 101.48, a price-to-earnings-growth ratio of 2.36 and a beta of 1.19.

Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 EPS for the quarter, topping the consensus estimate of $3.01 by $0.04. The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.62 billion. Waters had a return on equity of 11.27% and a net margin of 3.58%.The business's quarterly revenue was up 113.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.95 earnings per share. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. On average, analysts anticipate that Waters Corporation will post 14.57 EPS for the current fiscal year.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source